OTC MARKETS · ELOX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Eloxx Pharmaceuticals Inc

Eloxx Pharmaceuticals Inc

Pharmaceuticals
$17.57
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
ELOX
Eloxx Pharmaceuticals Inc
Fri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

85/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 7 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ELOX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ELOX catalysts
About Eloxx Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
1998
Employees
7
Country
US

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$17.57
Last session
Day high
$17.57
Last session
Day low
$17.57
Last session
Previous close
$17.57
52W high
$18.45
-4.77% from high
52W low
$0.0011
95% of range
Market cap
$736.8K
EPS
$-6.2400
Beta
10.69
Shares out
3.4M
Avg volume
64.4K
VWAP
$17.57
Last session
Price history computed in-house
1W
-4.77%
1M
+48.77%
3M
+75960.61%
1Y
+1597172.73%
YTD
+1597172.73%
SMA 50 $11.60 · above
SMA 200 Not reported · Not reported
52W position 95%

ELOX overview

Veridion Score
85
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ELOX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ELOX Form 4 filings
Public disclosures

Congress activity in ELOX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ELOX in the cached public ledger.

Federal contracts

ELOX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ELOX in this window.
Lobbying spend

ELOX lobbying filings, year to date.

Registered lobbying filings matched to Eloxx Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ELOX in this window.
Loading news for ELOX
Analyst ratings
Sovereign unlock shows live analyst consensus for ELOX.
Options
Sovereign unlock shows live options positioning for ELOX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.